Brandes Investment Partners, LP Ampio Pharmaceuticals, Inc. Transaction History

Brandes Investment Partners, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 15, 2018	SELL	$2.16 - $3.48 $108,000 - $174,000	-50,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$0.68 - $4.19 $34,000 - $209,500	50,000	50,000 $204,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Brandes Investment Partners, LP with notifications on news.